172 related articles for article (PubMed ID: 18922426)
1. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction.
De Hert SG; Lorsomradee S; vanden Eede H; Cromheecke S; Van der Linden PJ
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):699-705. PubMed ID: 18922426
[TBL] [Abstract][Full Text] [Related]
2. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
Eriksson HI; Jalonen JR; Heikkinen LO; Kivikko M; Laine M; Leino KA; Kuitunen AH; Kuttila KT; Peräkylä TK; Sarapohja T; Suojaranta-Ylinen RT; Valtonen M; Salmenperä MT
Ann Thorac Surg; 2009 Feb; 87(2):448-54. PubMed ID: 19161758
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial.
Momeni M; Rubay J; Matta A; Rennotte MT; Veyckemans F; Poncelet AJ; Clement de Clety S; Anslot C; Joomye R; Detaille T
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):419-24. PubMed ID: 20829069
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.
Lomivorotov VV; Cherniavskiy AM; Boboshko VA; Kornilov IA; Lomivorotov VN; Karaskov AM
Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):154-9. PubMed ID: 21471262
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
[TBL] [Abstract][Full Text] [Related]
9. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan increases bleeding risk after heart valve surgery: a retrospective analysis of a randomized trial.
Lahtinen P; Pitkänen O; Musialowicz T
J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1238-42. PubMed ID: 25281042
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery.
Al-Shawaf E; Ayed A; Vislocky I; Radomir B; Dehrab N; Tarazi R
J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):353-7. PubMed ID: 16750735
[TBL] [Abstract][Full Text] [Related]
14. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
Jörgensen K; Bech-Hanssen O; Houltz E; Ricksten SE
Circulation; 2008 Feb; 117(8):1075-81. PubMed ID: 18268152
[TBL] [Abstract][Full Text] [Related]
15. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery.
Leppikangas H; Järvelä K; Sisto T; Maaranen P; Virtanen M; Lehto P; Karlsson S; Kööbi T; Lindgren L
Br J Anaesth; 2011 Mar; 106(3):298-304. PubMed ID: 21258075
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan in aortic valve surgery: cardiac performance and recovery.
Järvelä K; Maaranen P; Sisto T; Ruokonen E
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):693-8. PubMed ID: 18922425
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.
Lomivorotov VV; Boboshko VA; Efremov SM; Kornilov IA; Chernyavskiy AM; Lomivorotov VN; Knazkova LG; Karaskov AM
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):596-603. PubMed ID: 22051419
[TBL] [Abstract][Full Text] [Related]
18. [A COMPARISON OF TWO APPROACHES FOR INTRAOPERATIVE LEVOSIMENDAN ADMINISTRATION IN CARDIAC SURGICAL PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION.].
Pasyuga VV; Belov SI; Yusupova ES; Adzhigaliev RR; Berezhnoy SA; Panov OS; Tarasov DG; Yavorovsky AG
Anesteziol Reanimatol; 2016 Sep; 61(5):334-338. PubMed ID: 29489098
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
Lahtinen P; Pitkänen O; Pölönen P; Turpeinen A; Kiviniemi V; Uusaro A
Crit Care Med; 2011 Oct; 39(10):2263-70. PubMed ID: 21666445
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial.
Nijhawan N; Nicolosi AC; Montgomery MW; Aggarwal A; Pagel PS; Warltier DC
J Cardiovasc Pharmacol; 1999 Aug; 34(2):219-28. PubMed ID: 10445673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
